Skip to content
1 min left
0% read
Axiom Bio logo

Axiom Bio

Technology Company
San Francisco, California, USA
Founded 2024
23

Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models.

Share:

Axiom's Predictive Models

Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data.

Axiom's AI models offer higher accuracy than advanced in vitro systems like 3D spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.

Frequently Asked Questions About Axiom Bio

Axiom Bio is an infrastructure company. Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models.

Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousand.

Axiom Bio has been operating since 2024. You can verify their legitimacy through their official website and social media presence.

Axiom Bio operates in the infrastructure sector of the cryptocurrency industry. Compare Axiom Bio with other infrastructure companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Axiom Bio, research their track record (operating since 2024), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Axiom Bio is based in San Francisco, California, USA, has been operating since 2024. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Axiom Bio is based in San Francisco, California, USA, North America.

Axiom Bio was founded in 2024. The company currently has 23 employees.

Axiom Bio Details

Axiom Bio Tags

More About Axiom Bio

Work Model Details
Employees work from physical offices.

Latest from Academy

RUNE Wallets Ranked by Security, Speed, and Cross-Chain Features

RUNE Wallets Ranked by Security, Speed, and Cross-Chain Features

RUNE is the native asset of THORChain, the cross-chain liquidity protocol whose vaults were exploited for more than $10 million in May 2026, hitting 12,847 wallets across Bitcoin, Ethereum, BNB Chain, and Base. The breach was a protocol-level failure no wallet could have prevented, but the wallet a holder used decided how fast they saw the pause warning and how exposed their funds were. Native wallets like Asgardex and THORWallet flagged the validator pause at the protocol level, while most multi-chain users only found out once Thorchain was trending online. This comparison grades the leading options for holding and swapping RUNE on security architecture, swap speed, and native cross-chain features. The takeaway is that for RUNE, your real risk exposure depends on wallet choice far more than on any rune price prediction.

8m
DeXe Built a DAO Platform That Actually Ships Products

DeXe Built a DAO Platform That Actually Ships Products

DeXe (DEXE) is a no-code DAO governance protocol whose DAO Studio lets anyone deploy and run a decentralized organization using more than sixty modular, audited smart contracts. DEXE traded around $13.59 with a market cap above $1.1 billion, up roughly 386% from its February lows, while protocol TVL climbed to $1.7 billion across more than one hundred DAOs. DeXe has shipped working software where most DAO tooling projects stalled, with audits from Cyfrin, Hacken, CertiK, and Ambisafe and staking yields reported up to 102% APR. Yet the holder base has stayed near 50,000 even as capital concentrated, raising a concentration question the price has yet to resolve. Regulatory tailwinds from MiCA and proposed U.S. rules could favor auditable on-chain governance, but execution still needs user growth to back the valuation.

Archie Dutton logoArchie DuttonMay 24, 2026
8m
Onyxcoin Survived Collapse While Others Died

Onyxcoin Survived Collapse While Others Died

Onyxcoin (XCN) should not still exist. The protocol behind it was hacked twice through the same CompoundV2 precision bug, the second time for more than $3.8 million in September 2024, and dozens of similar forks simply died. Instead, XCN trades around $0.0049 with a $186 million market cap, 97% below its 2022 all-time high. What kept it alive was not a slick press release but a DAO that put the rebuild to an on-chain vote: new architecture, a fresh whitepaper, gas-free wallets, and the Goliath proof-of-stake Layer 1, whose mainnet went live on March 27, 2026. The catch is that shipping products and seeing them adopted are very different things. Infrastructure and price still do not match up, and a live governance proposal to end all future token unlocks could flip the supply story deflationary. For any Onyxcoin price prediction in 2026, the real question is whether the rebuilt community can generate organic demand, or whether XCN keeps trading on listing pumps and milestone hype.

Archie Dutton logoArchie DuttonMay 23, 2026
9m